Effects of intensive lipid lowering on coronary plaque characteristics
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Innovating science and practice - Broadening the understanding of PCSK9i mAbInitiating PCSK9 mAb after ACS: When and how to start?
Prof. Wouter Jukema, MD, PhD
Pasquale Perrone-Filardi, MD, PhD
- Innovating science and practice - Broadening the understanding of PCSK9i mAbReal-world evidence with PCSK9i mAb; implications and lessons for current clinical use
Raul Santos, MD, PhD
Prof. Maciej Banach, MD, PhD